It is one of the main charms of blood coagulation that advanced biochemistry is continuous to everyday medical practice and vice versa. Common clinical facts hide the most enchanting enzymology. The prothrombin time (PT, thromboplastin time, Quick time) and the activated partial thromboplastin time (APTT) are perfect examples. Both are commonly used in the clinical laboratory as global tests for the function of the coagulation system and for the control of anticoagulant therapy. They are at the basis of the classical one-stage clotting factor determinations. Practice has taught us that the PT is perfectly suited for the control of anticoagulant therapy but not for measuring the effect of heparin, whereas the APTT can serve both purposes. Only recently was it found out why: the length of the APTT is primarily determinated by the time necessary for the activation of factor VIII by thrombin [1] . Now thrombin, of course, is the final enzyme of the coagulation cascade, whereas factor VIII is one of the factors necessary for its formation. The product actiyates one of the proteins instrumental in its own formation: a clearcut case of feedback activation. Obviously, if thrombin is quickly O l99l S. KargerAG, Basel 030 | -0 | 47 I 9 | | 02 | 4-Ot 89s2. 7 5 / O inactivated, as in the presence of heparin, the activation of factor VIII will take longer and the APTT will be prolonged. But one answer immediately engenders a number of questions: How does the frrst molecule of thrombin arise without the help of any activated factor VIII?, is there another way to activate factor VIII?, is factor VIIIa not absolutely necessary for thrombin formation in the APTT? And again: If the feedback effect shows up so readily with factor VIII in the intrinsic system, why don't we see it in the supposedly completely analogous situation with factor V, either intrinsically or extrinsically?
Thus, from a simple observation in the clinical laboratory one lands in a tangle of biochemical questions of the most interesting kind.
In the present issue, several articles are devoted to the discussion of feedback mechanisms in coagulation. The manuscripts were based upon the presentations of the authors at a symposium during the 21st Meeting of the Federation of the European Biochemical Societies organised by Prof. Elddi Susan and the present author (HCH). The reader will see how they span a wide range of interest, from fundamental to clinical. As a prelude to the more specialized articles that follow, we start with a short introduction to the feedback reactions ofcoagulation as we understand them now.
The Mechanism of Thrombin Formation
It is impossible to discuss feedback reactions in coagulation without first giving a general outline of the biochemical mechanism that leads to thrombin formation. Proenzyme to enzyme conversions form the backbone of this mechanism. As early as I 894, Pekelh anng l2l published experiments in which he isolated a prothrombin-containing fraction free offibrinogen and fibrinogen free of prothrombin. He observed that a tissue extract would form thrombin in his prothrombin preparation and drew the correct conclusion that he had isolated the proenzyme of the clotting enzyme. Incidentally, this is to our knowledge even the first time that a proenzyme was isolated and explicitly recognized. Clotting was recognized in 1963 to consist of a series of proenzyme to enzyme conversions 13, 41. At that time it was thought that all clotting factors were proenzymes which were converted into enzymes in a strict sequential order: the clotting cascade. Now we know that only the vitamin-Kdependent clotting factors II (prothrombin), VII, IX and X are the proenzymes. The sequence of activation is either VII + X + II or, alternatively VII -> IX -+ X -+ II (ftg. 1). Each of these activations takes place at a phospholipid surface in the presence of an accelerating helper protein, which is also adsorbed onto that surface (fi9.2). These helper proteins may conveniently be called paraenzymes. We prefer this term to the more commonly used'protein cofactor' because in general enzymology is by defrnition a second substrate (e.g. NADH), and thus suggests a mechanism that is quite different from what actually happens. The complete enzyme complex thus consists of the actual enzyme, that carries the active site (VII, IX or X), the paraenzyme [tissue factor (-thromboplastin), VIIIa or Val and the procoagulant phospholipid on which both are adsorbed. In order to be an effrcient procoagulant surface, the phospholipid has to be negatively charged. For all practical purposes, it has to contain phosphatidylserine.
In terms of enzyme kinetics, the phospholipid decreases the K-of the reaction and the paraenzyme increases the k""t. This means that, in the presence of a procoagulant phospholipid surface, the enzyme is easily saturated at normal plasma concentrations of the substrate, whereas it is far from saturated in free solution. The effect on h"t means that the presence of the paraenzyme increases the number of substrate molecules that one molecule of enzyme per unit time about one thousandfold. In terms of physiology, the phospholipid localizes the reaction at the site of a lesion in the vessel (any wound, but also e.g. an atheromatous lesion) and the paraenzyme serves to regulate the velocity of the reaction. The positive and negative feedback reactions of coagulation play their role primarily via activation and inactivation of the paraenzymes.
Positive and Negative Feedback in the Activation of Factor X Coagulation starts because factor VII combines with tissue factor, an integral membrane protein that occurs in cells sur- rounding the blood vessels and in the skin. In contrast to the other activation steps, here the phospholipid and the paraenzyme are always tightly bound together. Even though factor VII is not activated it shows already a certain, low activity when complexed to thromboplastin [see ref.
5 for further discussion and referencesl. It therefore can activate some factor X. Factor Xa, in a first positive feedback reaction then activates factor VII, which now becomes 10-100 times as active and starts to activate factor Xa at a high velocity. Factor Xa in plasma finds the extrinsic pathway inhibitor (EPI) [6, 7] . The factor Xa-EPI complex is a very effrcient inhibitor of the factor Vlla-thromboplastin complex. This is the negative feedback in factor X activation (frg. 3). The presence of factor Xa produces an inhibitor of the factor X-activating enzyme. The result is a sudden wave of factor Xa generation. A comparable mechanism acts on factor IX. After the acti-Activation of Platelets All cell membranes that have been investigated show an asymmetry of their phospholipid bilayer. What imports here is that the procoagulant phosphatidylserine is always found at the inside. This makes that intact cells will not provoke thrombin formation and hence do not cause thrombosis. There is one exception: the activated platelet. A transbilayer lipid movement makes that platelets, when they are activated, have at the outside the phosphatidylserine that originally is found at the inside only. The intact activated platelet thus becomes procoagulant [9] . Two physiological platelet activators produce this phenomenon: collagen and thrombin. In combination, they are even more active than the sum of their individual actions. The relative importance of the activators is dependent upon the platelet concentration. At 106 platelets/ml, collagen is more potent than thrombin, but at the normal concentration (108 platelets/ml plasma), thrombin is perfectly effective at a concentration as low as lO nM (0.050/o of the plasma prothrombin concentration), and collagen has no additional effect [10] .
It is easy to imagine a physiological scenario that shows the importance of these observations. As soon as a wound occurs the platelets gain access to the perivascular connective tissue, adhere to the connective tissue matrix (collagen, etc.) and produce phosphatidylserine at their outside surface. This phosphatidylserine fosters thrombin formation and by this thrombin more platelets will become activated, aggregating to those already adhering to the collagen. In the interstices of the platelet aggregate, plasma is caught. Activated clotting factors will not be washed away by the blood flowing by. The vation wave is over, the only way to form more factor Xa is via the factor IXa-factor Vllla-phospholipid complex. This may explain why hemophiliacs usually bleed in thromboplastin-poor organs like muscles and joints, rather than in thromboplastin rich organs like brain and lung. The quantitative kinetics of factor Xa activation in plasma still have to be determined. Preliminary results suggest that the pulse duration is always l-2 min and that the height of the pulse is determined by the amount of thromboplastin, but not linearly [8] .
The Thrombin-Dependent Positive Feedbacks
Thrombin has three positive feedback effects on its own formation: (a) The activation of platelets, (b) the activation of factor VIII and (c) the activation of factor V (fre.4). concentration of factor V in the crevices of the platelet plug will also be high, because it is released by the platelets. This will increase the local concentration of factor V, that in plasma is significantly lower than that of factor Xa (25 and 200 nM. The conditions are therefore perfectly suited to optimize thrombin generation: plenty ofprocoagulant phospholipid and of clotting factors.
The question of the origin of the first traces of activated clotting factor (Xa or thrombin) remains unsolved, however. We will discuss it in more detail below.
Activation of Factors V and VIII Factors V and VIII in the form in which they circulate in the plasma are incapable of serving as a paraenzyme in the clotting mechanism. They have to undergo limited proteolysis first. Thrombin is a very efficient enzyme here. Again the question remains where the frrst traces of factor V (VIII) activator come from. It is sure that factor Xa can serve this function lll, l2l, but it has also been shown that in plasma it hardly does [13] . When thrombin inactivation is enhanced, e.g. by the presence of heparin, the activation of factor VIII is retarded, which shows up as a prolongation of the APTT [for a discussion ofthe effects ofheparin also see ref.
141. The question of why the retardation ofthe activation offactor V does not show in a prolongation of the PT remains unsolved. In fact, the precise course of events during the prephase of thrombin formation (the lag phase) remains an enigma and requires thorough further investigation. One of the reasons for the observed difference between factors V and VIII possibly may be the fact that factor VIII circulates in a tight complex with Von Willebrand factor (VWF). The factor VIII activator, whatever it may be, therefore has to present itself in the fluid phase of the plasma in order to proteolyse the factor VIII that is attached to the VWF. After this proteolysis, factor VIIIa shows an affinity for procoagulant phospholipid rather than for VWF. Factor V, that has no plasma carrier, may possibly present itself at the phospholipid surface even before its activation and phospholipid bound activators like factor Xa or meizothrombin may attack it. Anyhow, thrombin (resp. factor Xa) formation appears to be critically dependent upon the presence of factor Va (resp. factor VIIIa) and the activation of factor V (resp. factor VIII) is critically dependent upon the presence of thrombin. The physiological mechanism that breaks this stalemate position remains to be found.
Thrombin-Dependent Negative Feedbacks
On normal endothelium one frnds the membrane (glyco)protein thrombomodulin, which has a high affrnity for thrombin. Thrombin adsorbed to thrombomodulin converts protein C into activated protein C (APC). APC attacks phospholipid-bound factor Va and factor VIIIa and destroys its activity by proteolytic action. The cofactor thus can no longer serve its helper function [5] (frg.5). By this mechanism, thrombin inhibits its own formation. Again, as with factor Xa, the active enzyme first enhances and later inhibits its own formation. Compared to the situation with factor Xa, however, the number of reactions in the inhibitory pathway is longer. Also here the presence of intact endothelium downstream of the thrombin source is necessary. This may lead to the speculation that this mechanism is primarily suitable for the prevention of the Pr.C extension of the thrombotic process to unaffected parts ofthe vascular bed, downstream of the lesion.
Continuous Extravascular Coagulation?
The proenzymes of blood coagulation are comparatively small molecules (< 70,000). The paraenzymes are of a much higher molecular weight (> 300,000). This makes that under normal circumstances the proenzymes may appear in the extravascular fluid whereas the paraenzymes will not. The phospholipids are present in the blood platelets which will not normally leave the vascular bed either. This opens the interesting possibility that at the sites where thromboplastin is present, i.e. in a layer ofperivascular cells, factor VII is activated and that this factor, at a yery low pace, may activate some factor X. This mechanism may produce low concentrations of thrombin near the cells that carry thromboplastin at their surface. As soon as there is a breach in a blood vessel the paraenzymes will appear, will be activated by the thrombin present, and speed up the process tremendously. Also the platelets arrive, adhere to the intentitial material of the connective tissue, flip-flop readily because of the thrombin already present and form a locus of high thrombogenic activity.
Anyhow, this is necessarily only part of the story, because blood drawn under circumstances that practically exclude contact with tissue still develops thrombin.
Nonlinearity and Flow Phenomena
Enzyme systems in which the quasi stationary rate ofa key reaction depends upon an enzyme or substrate concentration in an S-shaped, hysteresis type of function, are called nonlinear (frg.6). This type of response accounts for a number of properties that are commonly found in biological systems, such as thresholds, i.e. sudden changes of output at a given level of input; memory i.e. behavior dependent upon the previous history; morphogeneszs i.e. the formation of spatial structures. These phenomena are observed only at a certain degree of complexity of the enzyme system. Sel'kov [16] investigated the minimal requirements of complexity for nonlinearity to occur. One of his models is depicted in figure 7 . It is immediately evident that this general mechanism applies to thrombin formation. It may therefore be expected that, e.g., threshold phenomena are observed. This may be the background to the common observation that thrombosis occurs explosively when a thrombogenic threshold is passed and that it can be prevented by increasing this threshold via inhibition of the thrombin-generating mechanism, i.e. by oral anticoagulation or by heparin administration. In simulation experiments it is indeed observed that below a critical limit of factor Xa thrombin generation will not ensue, whereas above that limit it is explosive [6] .
It appears that no realistic picture of the reaction mechanism of thrombin formation can be sketched without taking positive and negative feedback reactions into account. This may be a necessary level of complication, it is by no means sufficient. As already hinted at above, it is impossible to obtain a picture of thrombin generation that approaches reality without taking into account that in (patho)-physiology the generation of thrombin is not a merely chemical process but linked to the appearance of macroscopic procoagulant surfaces. Recent research made it clear that such surfaces offer conditions that differ essentially from those in a test tube where the phospholipids are present as a suspension ofvesicles [17] . This indicates that, in order to obtain a realistic picture of thrombin generation under physiological and pathological conditions, one has to study it in the presence of macroscopic surfaces and under flow conditions. The elegant experiments started [ 8] may be at the basis ment here.
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